All for Joomla All for Webmasters

(+233) - 244987074 , (+233) - 267987074

info@de-montag.com / roldemontag@gmail.com

×

Warning

Copy failed.
JUser: :_load: Unable to load user with ID: 61534

The Endocrine Society now issued a Clinical Practice Guideline (CPG) advising against using testosterone treatment in healthy women. Although the FDA approved testosterone therapy for the treatment of ailments affecting the testes, pituitary and hypothalamus, it hasn't been approved for treating age-related declines in testosterone levels. The U.S. National Institute on Aging is also expected to release the results of research on the safety of testosterone. The study involved roughly 800 elderly men with low testosterone and symptoms associated with this ailment, including http://tinyurl.com/jkhvqy9 physical and sexual dysfunction. The research is expected to shed more light on the security of testosterone treatment, since the men's heart health was carefully monitored.

The recent contradictory findings on testosterone treatment prompted his team to run a large systematic literature search for studies assessing the relationship between testosterone replacement therapy and cardiovascular events among guys and Patel. An estimated 13 million men in America suffer with low testosterone, which happens when the body does not make enough hormones because of a difficulty with the testicles or pituitary gland. This explains the sudden weight gain, clear aging and loss of energy of an individual.

And many women have a knee-jerk feeling that any hormone treatment can raise their risk of breast cancer. Nevertheless, clinical studies show that testosterone not only doesn't increase a woman's risk of breast cancer , it may play a vital role in warding off the disease. Glaser believes this will probably remain the status quo for a while, given the prohibitive cost of running the long term safety studies needed to win FDA acceptance that is more total.